120 related articles for article (PubMed ID: 23970385)
21. [Abdominal presentation of B-cell non-Hodgkin's lymphoma (B-NHL) - surgical treatment and its results. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
Kazanowska B; Wróbel G; Jaworski W; Bogusławska-Jaworska J; Jeleń M; Armata J; Balcerska A; Bubala H; Dluzniewska A; Kołecki P; Kowalczyk J; Kurylak A; Matysiak M; Ploszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopylo B; Stańczak E; Stefaniak MJ; Stefańska K; Wysocki M; Gacka M
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):57-66. PubMed ID: 12021463
[TBL] [Abstract][Full Text] [Related]
22. Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
Acquatella G; Insausti CL; García R; Gómez R; Hernández M; Carneiro M; Santos S; Nouel A
Pediatr Blood Cancer; 2004 Oct; 43(5):580-6. PubMed ID: 15382276
[TBL] [Abstract][Full Text] [Related]
23. Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.
Worch J; Rohde M; Burkhardt B
Pediatr Hematol Oncol; 2013 Sep; 30(6):465-83. PubMed ID: 23570584
[TBL] [Abstract][Full Text] [Related]
24. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
25. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM
Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783
[TBL] [Abstract][Full Text] [Related]
26. B cell non-Hodgkin's lymphoma: experience from a tertiary care cancer center.
Prakash G; Sharma A; Raina V; Kumar L; Sharma MC; Mohanti BK
Ann Hematol; 2012 Oct; 91(10):1603-11. PubMed ID: 22584851
[TBL] [Abstract][Full Text] [Related]
27. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and outcome analysis of pediatric B-cell non-Hodgkin's lymphoma. Experience with FAB-LMB 96 and UKCCSG B-cell NHL guidelines in a developing country.
Ahmad N; Zaidi A; Badar F; Maaz AU; Akram MS
Asia Pac J Clin Oncol; 2010 Mar; 6(1):49-56. PubMed ID: 20398038
[TBL] [Abstract][Full Text] [Related]
29. Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.
Sandlund JT; Hudson MM; Kennedy W; Onciu M; Kastan MB
Pediatr Blood Cancer; 2014 Feb; 61(2):360-2. PubMed ID: 23900766
[TBL] [Abstract][Full Text] [Related]
30. Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study.
Gururangan S; Sposto R; Cairo MS; Meadows AT; Finlay JL
J Clin Oncol; 2000 May; 18(10):2017-25. PubMed ID: 10811665
[TBL] [Abstract][Full Text] [Related]
31. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
32. Treatment of B-cell lymphoma with LMB modified protocols in Africa--report of the French-African Pediatric Oncology Group (GFAOP).
Harif M; Barsaoui S; Benchekroun S; Bouhas R; Doumbé P; Khattab M; Ladjaj Y; Moreira C; Msefer-Alaoui F; Patte C; Rakotonirina G; Raphael M; Raquin MA; Lemerle J
Pediatr Blood Cancer; 2008 Jun; 50(6):1138-42. PubMed ID: 18213709
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
[TBL] [Abstract][Full Text] [Related]
34. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A
Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Madani A; Benhmiddoune L; Zafad S; Harif M; Quessar A; Benchekroun S
Bull Cancer; 2005 Feb; 92(2):193-8. PubMed ID: 15749649
[TBL] [Abstract][Full Text] [Related]
36. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
Diviné M; Casassus P; Koscielny S; Bosq J; Sebban C; Le Maignan C; Stamattoulas A; Dupriez B; Raphaël M; Pico JL; Ribrag V; ;
Ann Oncol; 2005 Dec; 16(12):1928-35. PubMed ID: 16284057
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.
Cairo MS; Krailo MD; Morse M; Hutchinson RJ; Harris RE; Kjeldsberg CR; Kadin ME; Radel E; Steinherz LJ; Morris E; Finlay JL; Meadows AT
Leukemia; 2002 Apr; 16(4):594-600. PubMed ID: 11960338
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis and treatment of primary colorectal non-Hodgkin's lymphoma: analysis of 52 cases].
Huang S; Zheng ZX; Xu Q; Yuan XH
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):305-8. PubMed ID: 23985262
[TBL] [Abstract][Full Text] [Related]
39. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
Sun XF; Zhen ZJ; Xiang XJ; Ling JY; Peng RJ; Xia Y; Zheng L; Luo WB; Lin H; Guan ZZ
Ai Zheng; 2009 May; 28(5):506-10. PubMed ID: 19624879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
